Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

M6G, A New Morphine Derivative For Post-Operative Pain Relief

Drug (Brand/Generic)

Morphine-6-Glucuronide (M6G)

Company/Licensee

PAION AG

Therapy Class

Opioid

Product Description

Morphine derivative

Current Indication

Severe post-operative pain

Market Sector

CNS – pain

Development Status

Phase III
Expand
Close
Close
Close

Go Top